Skip to main content

18 January 2022

Last updated: Monday 17 January 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Targeting new medicines at Roche

Sunday 12 January 2014

Interviewee/Contributor

Max Hasmann

Organisation

Roche Group

Organisations

Molecular Health GmbH
Karolinska Institutet
AYOXXA Biosystems GmbH
Lawford Davies Denoon
Forbion
ETH Zürich
ALK-Abelló A/S
Special Advisor at I and IR
Jon Rees Associates Ltd
Kilburn & Strode LLP

Interviewees and Contributers

Urban Lendahl
Donald Light
Martin Whitaker
Ulrich Dauer
Andreas Posch, Achim Plum and Richard Zahrl
Todd McAllister
Karen Finn
Tara Raveendran
Steven Powell
Anthony Sedgwick

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Anders Tullgren joins BerGenBio

Thursday 13 January 2022

BiVictriX Therapeutics appoints CFO

Thursday 13 January 2022

Faron appoints new CMO

Thursday 13 January 2022

MiNA Therapeutics appoints directors

Thursday 13 January 2022

Agomab expands leadership team

Thursday 13 January 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form